An observational study in Infertility, sponsored by Clinique Ovo. Terminated at 1 site in Canada. Open to female participants aged 18 Years to 43 Years. Per ClinicalTrials.gov, last updated 2022-09-10.
Sponsored by Clinique Ovo · Observational
Recently, scientists look into G-CSF (Granulocyte - Colony Stimulatin Factor). The use of this molecule is increasing in reproduction pathology. High level of follicular and blood G-CSF on the day of oocyte retrieval could correlate with higher pregnancy and implantation rates.
2,506 studies on the registry are indexed under Infertility; 407 are open to participants now.
This study's enrollment of 152 is below the median of 200 across 714 observational studies indexed under Infertility.
Browse Infertility studies →Clinique Ovo is the lead sponsor of 35 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Women with a natural cycle of an In Vitro Fecondation
Exclusion Criteria:
Patient following a natural In Vitro Fecondation cycle
Procedure: Blood test
Taking blood sample of the patient during the day 3, triggering day, oocyte collection day and pregnancy test day. Taking the follicular fluid during the oocyte collection day
Serum and / or follicular minimum level of G-CSF predictive of pregnancy
Time frame: 6 months
This study is terminated, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Clinique Ovo